[1]
Kumar, M.; Jain, S.; Deep, A. Syntheses and antimicrobial activities of 2, 3-disubstituted-4-thiazolidinone terivatives. Lat AM J Phar., 2011, 30(2), 388-391.
[2]
Tenover, F.C. Mechanisms of antimicrobial resistance in bacteria. Am. J. Med., 2006, 119(6)(Suppl. 1), S3-S10.
[3]
Pfeltz, R.F.; Wilkinson, B.J. The escalating challenge of vancomycin resistance in Staphylococcus aureus. Curr. Drug Targets Infect. Disord., 2004, 4(4), 273-294.
[4]
Desai, N.C.; Dodiya, A.M.; Shihora, P.N. A clubbed quinazolinone and 4-thiazolidinone as potential antimicrobial agents. Med. Chem. Res., 2012, 21(8), 1577-1586.
[5]
El-Gaby, M.S.; El-Hag Ali, G.A.; El-Maghraby, A.A.; Abd El-Rahman, M.T.; Helal, M.H. Synthesis, characterization and in vitro antimicrobial activity of novel 2-thioxo-4-thiazolidinones and 4,4′-bis(2-thioxo-4-thiazolidinone-3-yl)diphenylsulfones. Eur. J. Med. Chem., 2009, 44(10), 4148-4152.
[6]
Deep, A.; Jain, S.; Sharma, P.C.; Mittal, S.K.; Phogat, P.; Malhotra, M. Synthesis, characterization and antimicrobial evaluation of 2,5-disubstituted-4-thiazolidinone derivatives. Arab. J. Chem., 2014, 7, 287-291.
[7]
Wu, S.; Guo, W.; Teraishi, F.; Pang, J.; Kaluarachchi, K.; Zhang, L.; Davis, J.; Dong, F.; Yan, B.; Fang, B. Anticancer activity of 5-benzylidene-2-phenylimino-1, 3-thiazolidin-4-one (BPT) analogs. Med. Chem., 2006, 2(6), 597-605.
[8]
Deep, A.; Kumar, P.; Narasimhan, B.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B. Synthesis, antimicrobial, anticancer evaluation of 2-(aryl)-4- thiazolidinone derivatives and their QSAR studies. Curr. Top. Med. Chem., 2015, 15(11), 990-1002.
[9]
Srivastava, T.; Gaikwad, A.K.; Haq, W.; Sinha, S.; Katti, S.B. Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents. ARKIVOC, 2005, (ii), 120-130.
[10]
Patel, R.B.; Desai, P.S.; Desai, K.R.; Chikhalia, K.H. Synthesis of pyrimidine based thiazolidinones and azetidinones: Antimicrobial and antitubercular agents. Indian J. Chem., 2006, 45B, 773-778.
[11]
Deep, A.; Jain, S.; Sharma, P.C. Synthesis and anti-inflammatory activity of some novel biphenyl-4-carboxylic acid 5-(arylidene)-2-(aryl)-4-oxothiazolidin-3-yl amides. Acta Pol. Pharm., 2010, 67(1), 63-67.
[12]
Deep, A.; Jain, S.; Sharma, P.C.; Phogat, P.; Malhotra, M. Synthesis of 2-(aryl)-5-(arylidene)-4-thiazolidinone derivatives with potential analgesic and anti-inflammatory activity. Med. Chem. Res., 2012, 21, 1652-1659.
[13]
Ottanà, R.; Maccari, R.; Giglio, M.; Del Corso, A.; Cappiello, M.; Mura, U.; Cosconati, S.; Marinelli, L.; Novellino, E.; Sartini, S.; La Motta, C.; Da Settimo, F. Identification of 5-arylidene-4-thiazolidinone derivatives endowed with dual activity as aldose reductase inhibitors and antioxidant agents for the treatment of diabetic complications. Eur. J. Med. Chem., 2011, 46(7), 2797-2806.
[14]
Kumar, R.; Subban, R.; Sundaram, K.; Venkatachalapthi, S.; Ali, M.S.A. Conventional and microwave assisted synthesis of 2-aminothiazoles and oxazoles and their anti cancer activity. Indo Am. J. Pharm. Res., 2015, 5(1), 555-561.
[15]
Pharmacopoeia, Pharmacopoeia of India, vol. II. Ministry of Health Department, Govt. of India, New Delhi, pp. A-88,, 1996.
[16]
Cruickshank, R.; Duguid, J.P.; Marmion, B.P.; Swain, R.H.A. The Enterobacteriaceae: Salmonella. In: Medical Microbiology, 12th ed; Churchill Livingstone: Edinburgh, London, New York, 1975; Vol. 11, pp. 403-419.